332 related articles for article (PubMed ID: 24074450)
1. Ribosomal protein S14 silencing inhibits growth of acute myeloid leukemia transformed from myelodysplastic syndromes via activating p53.
Wang L; Luo J; Nian Q; Xiao Q; Yang Z; Liu L
Hematology; 2014 Jun; 19(4):225-31. PubMed ID: 24074450
[TBL] [Abstract][Full Text] [Related]
2. SPARC silencing inhibits the growth of acute myeloid leukemia transformed from myelodysplastic syndrome via induction of cell cycle arrest and apoptosis.
Nian Q; Xiao Q; Wang L; Luo J; Chen LP; Yang ZS; Liu L
Int J Mol Med; 2014 Apr; 33(4):856-62. PubMed ID: 24535175
[TBL] [Abstract][Full Text] [Related]
3. Myelodysplastic syndromes with 5q deletion: pathophysiology and role of lenalidomide.
Gaballa MR; Besa EC
Ann Hematol; 2014 May; 93(5):723-33. PubMed ID: 24627193
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
Kurotaki H; Tsushima Y; Nagai K; Yagihashi S
Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673
[TBL] [Abstract][Full Text] [Related]
5. Low RPS14 expression in MDS without 5q - aberration confers higher apoptosis rate of nucleated erythrocytes and predicts prolonged survival and possible response to lenalidomide in lower risk non-5q- patients.
Wu L; Li X; Xu F; Zhang Z; Chang C; He Q
Eur J Haematol; 2013 Jun; 90(6):486-93. PubMed ID: 23506134
[TBL] [Abstract][Full Text] [Related]
6. A novel all-trans retinoic acid derivative inhibits proliferation and induces apoptosis of myelodysplastic syndromes cell line SKM-1 cells via up-regulating p53.
Du Y; Li LL; Chen H; Wang C; Qian XW; Feng YB; Zhang L; Chen FH
Int Immunopharmacol; 2018 Dec; 65():561-570. PubMed ID: 30415163
[TBL] [Abstract][Full Text] [Related]
7. High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome.
Han X; Medeiros LJ; Zhang YH; You MJ; Andreeff M; Konopleva M; Bueso-Ramos CE
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S30-8. PubMed ID: 27155969
[TBL] [Abstract][Full Text] [Related]
8. SPARC ectopic overexpression inhibits growth and promotes programmed cell death in acute myeloid leukemia transformed from myelodysplastic syndrome cells, alone and in combination with Ara-C treatment.
Nian Q; Chi J; Xiao Q; Wei C; Costeas P; Yang Z; Liu L; Wang L
Oncol Rep; 2015 Sep; 34(3):1406-14. PubMed ID: 26165695
[TBL] [Abstract][Full Text] [Related]
9. The effect of miR-223 on cellular behaviour in non-5q myelodysplastic syndromes through targeting RPS14.
Nie Y; Wang S; Yu Y; Zuo X; Xiong B
Pathology; 2020 Aug; 52(5):552-560. PubMed ID: 32571542
[TBL] [Abstract][Full Text] [Related]
10. miR-378 inhibits cell growth and enhances apoptosis in human myelodysplastic syndromes.
Kuang X; Wei C; Zhang T; Yang Z; Chi J; Wang L
Int J Oncol; 2016 Nov; 49(5):1921-1930. PubMed ID: 27633496
[TBL] [Abstract][Full Text] [Related]
11. Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9.
Schneider RK; Schenone M; Ferreira MV; Kramann R; Joyce CE; Hartigan C; Beier F; Brümmendorf TH; Germing U; Platzbecker U; Büsche G; Knüchel R; Chen MC; Waters CS; Chen E; Chu LP; Novina CD; Lindsley RC; Carr SA; Ebert BL
Nat Med; 2016 Mar; 22(3):288-97. PubMed ID: 26878232
[TBL] [Abstract][Full Text] [Related]
12. SPAG6 silencing inhibits the growth of the malignant myeloid cell lines SKM-1 and K562 via activating p53 and caspase activation-dependent apoptosis.
Yang B; Wang L; Luo X; Chen L; Yang Z; Liu L
Int J Oncol; 2015 Feb; 46(2):649-56. PubMed ID: 25405588
[TBL] [Abstract][Full Text] [Related]
13. Silencing HO-1 sensitizes SKM-1 cells to apoptosis induced by low concentration 5-azacytidine through enhancing p16 demethylation.
Wang P; Ma D; Wang J; Fang Q; Gao R; Wu W; Lu T; Cao L
Int J Oncol; 2015 Mar; 46(3):1317-27. PubMed ID: 25585641
[TBL] [Abstract][Full Text] [Related]
14. [Proliferation promotion and apoptotic inhibition effects of ribosomal protein RPL36A small interference RNA on U937 cells].
Wu LM; Wang SY; Wang SX; Huang YM; Li JG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):344-9. PubMed ID: 20416165
[TBL] [Abstract][Full Text] [Related]
15. [The expression of beta-tubulin gene in myelodysplastic syndrome evoluting to leukemia].
Ma Y; Chen BB; Xu XP; Lin GW
Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):377-80. PubMed ID: 27143188
[TBL] [Abstract][Full Text] [Related]
16. CircZBTB46 predicts poor prognosis and promotes disease progression of myelodysplastic syndromes and acute myeloid leukemia.
Li S; Zhao G; Wu W; Li N; Wang Q; Wang W; Song X; Wang X
Clin Exp Med; 2023 Dec; 23(8):4649-4664. PubMed ID: 37930606
[TBL] [Abstract][Full Text] [Related]
17. Arsenic disulfide-triggered apoptosis and erythroid differentiation in myelodysplastic syndrome and acute myeloid leukemia cell lines.
Hu XM; Yuan B; Tanaka S; Song MM; Onda K; Tohyama K; Zhou AX; Toyoda H; Hirano T
Hematology; 2014 Sep; 19(6):352-60. PubMed ID: 24192507
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of
Jiang M; Chen Y; Deng L; Luo X; Wang L; Liu L
DNA Cell Biol; 2019 May; 38(5):476-484. PubMed ID: 30835546
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome.
Huang HH; Chen FY; Chou WC; Hou HA; Ko BS; Lin CT; Tang JL; Li CC; Yao M; Tsay W; Hsu SC; Wu SJ; Chen CY; Huang SY; Tseng MH; Tien HF; Chen RH
BMC Cancer; 2019 Jun; 19(1):617. PubMed ID: 31234830
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Effect and Molecular Mechanism of Homoharringtonine and Bortezomib on SKM-1 Cell Apoptosis.
Zhang J; Chen B; Wu T; Wang Q; Zhuang L; Zhu C; Fan N; Qing W; Ma Y; Xu X
PLoS One; 2015; 10(11):e0142422. PubMed ID: 26544558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]